NCITA is a network of medical imaging experts and scientists across nine leading cancer imaging institutions across the UK, and we are building a unified infrastructure for discovery, validation and adoption of cancer imaging biomarkers into clinical trials and the NHS.

On the 27th April 2021, NCITA held a workshop on ‘Nuclear Medicine in Oncology’. The workshop provided a detailed overview of nuclear medicine in oncology, and a mix of researchers, students and managers joined the workshop to learn more about this area.

In the final talk, Dr Daniel McGowan, Principal Clinical Scientist (University of Oxford) gives an introduction to ‘Legislation and Regulation around Nuclear Medicine’. Daniel covers types of background and environmental radiation, UK Radiation Protection Legislation, mitigation and ways of preventing contamination, as well as an overview of Environmental Permitting Regulations (EPR) 2016, Ionising Radiation (Medical Exposure) Regulations (IRMER) 2017 and the application of IRMER aimed at protecting patients from over-exposure or accidental exposure. Daniel also highlights the Integrated Research Application System (IRAS) for acknowledging the use of ionising radiation in clinical research studies, the UK HRA Radiation Assurance process including the role of the lead Clinical Radiation Expert (CRE) and lead Medical Physics Expert (MPE) and Administration of Radioactive Substances Advisory Committee (ARSAC) regulations.

For more of our webinars and workshops please visit: [ Ссылка ]

свернуть